Couverture de The Lancet Infectious Diseases in conversation with

The Lancet Infectious Diseases in conversation with

The Lancet Infectious Diseases in conversation with

De : The Lancet Group
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

Saleha Hassan, Senior Editor at The Lancet Infectious Diseases, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from polio eradication in Africa to COVID-19 vaccines in Hong Kong, the treatment of early syphilis in adults to Mpox in the UK, and more.

© 2026 The Lancet Group Hygiène et vie saine Maladie et pathologies physiques Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Julia Moore Vogel and Danilo Buonsenso on long COVID

      Julia Moore Vogel and Danilo Buonsenso on long COVID
      Dec 19 2025

      Dr Julia Moore Vogel and Dr Danilo Buonsenso discuss various aspects of long COVID including epidemiology, pathophysiology, underlying mechanisms, management, latest research developments, difficulties in conducting clinical trials, and future research priorities.

      Continue this conversation on social!
      Follow us today at...
      https://thelancet.bsky.social/
      https://instagram.com/thelancetgroup
      https://facebook.com/thelancetmedicaljournal
      https://linkedIn.com/company/the-lancet
      https://youtube.com/thelancettv
      Afficher plus Afficher moins
      28 min
    • In Conversation with Steven Tong and Joshua Davis on adaptive platform trials

      In Conversation with Steven Tong and Joshua Davis on adaptive platform trials
      Oct 23 2025

      Professors Steven Tong and Joshua Davis discuss all aspects of adaptive platform trials including advantages, disadvantages, differences from conventional trials, and tips for setting up and assessing them.

      They also highlight several adaptive platform trials currently in the pipeline that could influence infectious disease clinical practise in the future.

      Click here to read our latest issue

      Continue this conversation on social!
      Follow us today at...
      https://thelancet.bsky.social/
      https://instagram.com/thelancetgroup
      https://facebook.com/thelancetmedicaljournal
      https://linkedIn.com/company/the-lancet
      https://youtube.com/thelancettv
      Afficher plus Afficher moins
      26 min
    • Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard on artificial intelligence and infectious diseases

      Anna Odone, Jesus Rodriguez-Manzano, and Alex Howard on artificial intelligence and infectious diseases
      Sep 16 2025

      Professor Ana Odone, Dr Jesus Rodriguez-Manzano, and Dr Alex Howard discuss their new Series of papers on artificial intelligence and infectious diseases intended to support the infectious diseases community in understanding this evolving landscape and in actively shaping artificial intelligence integration into practice.

      Read the full Series here:

      https://www.thelancet.com/series-do/artificial-intelligence-and-infectious-diseases?dgcid=buzzsprout_icw_podcast_laninfaiandid25_laninf

      Continue this conversation on social!
      Follow us today at...
      https://thelancet.bsky.social/
      https://instagram.com/thelancetgroup
      https://facebook.com/thelancetmedicaljournal
      https://linkedIn.com/company/the-lancet
      https://youtube.com/thelancettv
      Afficher plus Afficher moins
      29 min
    Aucun commentaire pour le moment